HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.

AbstractINTRODUCTION:
Hypoxia induced factors (HIFs) are at the heart of the adaptive mechanisms cancer cells must implement for survival. HIFs are regulated by four hydroxylases; Prolyl hydroxylase (PHD)-1,-2,-3 and factor inhibiting HIF (FIH). We aimed to investigate the prognostic impact of these oxygen sensors in NSCLC.
METHODS:
Tumor tissue samples from 335 resected stages I to IIIA NSCLC patients was obtained and tissue microarrays (TMAs) were constructed. Hydroxylase expression was evaluated by immunohistochemistry.
PRINCIPAL FINDINGS:
There was scorable expression for all HIF hydroxylases in tumor cells, but not in stroma. In univariate analyses, high tumor cell expression of all the HIF hydroxylases were unfavorable prognosticators for disease-specific survival (DSS); PHD1 (P = 0.023), PHD2 (P = 0.013), PHD3 (P = 0.018) and FIH (P = 0.033). In the multivariate analyses we found high tumor cell expression of PHD2 (HR = 2.03, CI 95% 1.20-3.42, P = 0.008) and PHD1 (HR = 1.45, CI 95% 1.01-2.10, P = 0.047) to be significant independent prognosticators for DSS. Besides, there was an additive prognostic effect by the increasing number of highly expressed HIF hydroxylases. Provided none high expression HIF hydroxylases, the 5-year survival was 80% vs. 23% if all four were highly expressed (HR = 6.48, CI 95% 2.23-18.8, P = 0.001).
CONCLUSIONS:
HIF hydroxylases are, in general, poor prognosticators for NSCLC survival. PHD1 and PHD2 are independent negative prognostic factors in NSCLC. Moreover, there is an additive poor prognostic impact by an increasing number of highly expressed HIF hydroxylases.
AuthorsSigve Andersen, Tom Donnem, Helge Stenvold, Samer Al-Saad, Khalid Al-Shibli, Lill-Tove Busund, Roy M Bremnes
JournalPloS one (PLoS One) Vol. 6 Issue 8 Pg. e23847 ( 2011) ISSN: 1932-6203 [Electronic] United States
PMID21887331 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Repressor Proteins
  • Mixed Function Oxygenases
  • Dioxygenases
  • HIF1AN protein, human
  • EGLN1 protein, human
  • Procollagen-Proline Dioxygenase
  • EGLN3 protein, human
  • Hypoxia-Inducible Factor-Proline Dioxygenases
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung (mortality, pathology)
  • Dioxygenases (analysis, biosynthesis)
  • Female
  • Humans
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Immunohistochemistry
  • Lung Neoplasms (mortality, pathology)
  • Male
  • Middle Aged
  • Mixed Function Oxygenases (analysis, biosynthesis)
  • Predictive Value of Tests
  • Procollagen-Proline Dioxygenase (analysis, biosynthesis)
  • Prognosis
  • Repressor Proteins (analysis, biosynthesis)
  • Survival Analysis
  • Tissue Array Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: